NCT02076269View on ClinicalTrials.gov

Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

No Intervention

Patients are receiving no treatment in this study and there is no investigational product involved

Trial Locations (1)

2650

GSK Investigational Site, Edegem

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02076269 - Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison | Biotech Hunter | Biotech Hunter